ESTRO 36 Programme book and exhibition guide

> SBRT benefit in oligometastatic prostate cancer patients detected by [18F]fluoromethylcholine PET/CT E. Bouman-Wammes (The Netherlands), J.M. Van Dodewaard- de Jong, M. Dahele, M.C.F. Cysouw, O.S. Hoekstra, A.H.M. Piet, A.J.M. Van den Eertwegh, H.M.W. Verheul, D.E. Oprea-Lager, V.M. H. > Moderate hypofractionated-imrt of prostate bed after radical prostatectom: acute toxicity J. Valero Albarran (Spain), A. Ruiz Herrero, A. Montero, E. Sanchez, E. Castro, D. Olmos, M. Hernandez, R. Ciervide, X. Chen, B. Alvarez, M. Garcia Aranda, M. Lopez, M. Serrano, L. Osorio, M. Asenjo, P. Fernandez Leton, A. Acosta, O. Hernando Requejo, C. Rubio > Prostate postoperative hypofractionated radiotherapy: a single institution experience with Tomo S. Gomellini (Italy), B. Shima, R. Barbara, C. Caruso, A.D. Andrulli, U. De Pula S. Tyldesley (Canada), S. Parimi, E. Tsang, F. Bachand, M. Aparicio, G. Duncan, K. Sunderland, R. Olson, H. Pai, A. Alexander, V. Lapointe, K. Chi > Stereotactic body radiotherapy for oligometastatic prostate cancer recurrence after local treatment. P.A. Laurent (France), E. Martin, F. Cousin, M. Quivrin, F. Bidault, F. Mazoyer, A. Bertaut, G. Crehange > Prostate SBRT in 5 fractions, report of 185 patients and late toxicity analysis. P. Castro Peña (Argentina), O. Muriano, A. Henao, P. Murina, C. Niño de Guzman, D. Venencia, S. Zunino > Correlations between dose to small intestine and bladder volume in patients receiving pelvic IMRT M. Alfayez (UK), A. Sadozye > Clinical efficacy of a dose escalated and hypofractionated pelvic IMRT study in prostate cancer A. Khan (UK), K. Thomas, L. Truelove, M. Ferreira, S. Gulliford, H. McNair, C. Parker, R. Huddart, D. Dearnaley > Pain response in a population-based study of Radium-223 for metastatic prostate cancer

ELECTRONIC POSTERS

EP-1356

EP-1357

EP-1358

EP-1359

EP-1360

EP-1361

EP-1362

EP-1363

POSTERS AND ELECTRONIC POSTERS | Programme and Exhibition Guide

260